Revenue: The sum of all revenue fields included for a company's operating activities.
Xilio Therapeutics, Inc. (XLO) had Revenue of $6.34M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$6.34M |
$-58.24M |
|
-- |
|
$6.34M |
|
$66.93M |
|
$-60.58M |
|
$2.34M |
|
$-58.24M |
|
$-58.24M |
|
$-58.24M |
|
$-58.24M |
|
$-58.24M |
|
$-58.24M |
|
$-60.58M |
|
$-58.94M |
|
53.51M |
|
53.51M |
|
$-1.09 |
|
$-1.09 |
|
| Balance Sheet Financials | |
$60.23M |
|
$4.47M |
|
$10.84M |
|
$71.08M |
|
$27.26M |
|
-- |
|
$26.22M |
|
$53.48M |
|
$17.60M |
|
$17.60M |
|
$17.60M |
|
45.76M |
|
| Cash Flow Statement Financials | |
$-18.38M |
|
$-0.04M |
|
$29.20M |
|
$46.29M |
|
$57.07M |
|
$10.78M |
|
$6.43M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.21 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-954.95% |
|
-954.95% |
|
-929.04% |
|
-918.05% |
|
-918.05% |
|
$-18.41M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
-- |
|
-- |
|
-- |
|
-330.95% |
|
-330.95% |
|
-81.94% |
|
-330.95% |
|
$0.38 |
|
$-0.34 |
|
$-0.34 |
|